Maura Casciola
Research Subjects
Maura Casciola has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Ksenia Blinova
Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, U.S. Food and Drug Administration Silver Spring Maryland USA
4 shared publications - Tromondae K. Feaster
Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring Maryland USA
4 shared publications - Akshay Narkar
Department of Cell Biology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
3 shared publications - Francesca Apollonio
Sapienza University of Rome
3 shared publications - Micaela Liberti
Sapienza University of Rome
3 shared publications - Agnese Denzi
Center for Life Nano Science at Sapienza, Istituto Italiano di Tecnologia, Rome, Italy
2 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (Supplement) , ii82-ii98
Sedation and anaesthesia in pulsed-field ablation for atrial fibrillation: mechanisms, procedural requirements, and real-world practice
Pulsed-field ablation (PFA) has rapidly emerged as an important energy source for atrial fibrillation ablation, offering tissue selectivity and procedural efficiency while introducing specific anaesthetic and sedation requirements. This narrative review examines the rationale for anaesthesia and sedation during PFA, the mechanisms underlying pain, involuntary movement, and neuromuscular stimulation, and the implications of catheter design, waveform characteristics, and patient-related factors for peri-procedural management. Available evidence indicates that both deep sedation and general anaesthesia can provide safe and effective procedural conditions when supported by appropriate monitoring, airway rescue capability, and experienced multidisciplinary teams. Deep sedation may offer advantages in workflow, recovery, and patient-centred care, particularly for standard pulmonary vein isolation procedures using contemporary biphasic systems with reduced muscle activation, whereas general anaesthesia remains appropriate for complex procedures, patients with substantial comorbidity, or settings in which complete immobility and airway control are essential. Current real-world practice is highly heterogeneous across regions and institutions, reflecting differences in regulations, staffing models, procedural complexity, and local expertise rather than a universally accepted standard. Overall, anaesthetic strategy in PFA should be individualised according to patient risk profile, expected procedural demands, and device-specific stimulation burden. Further prospective comparative studies are needed to define optimal sedation depth, standardise monitoring and outcome measures, and clarify how emerging technologies may enable lighter yet still effective sedation pathways.
- 21 October 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (Supplement) , ii82-ii98
Open AccessSedation and anaesthesia in pulsed-field ablation for atrial fibrillation: mechanisms, procedural requirements, and real-world practice
Pulsed-field ablation (PFA) has rapidly emerged as an important energy source for atrial fibrillation ablation, offering tissue selectivity and procedural efficiency while introducing specific anaesthetic and sedation requirements. This narrative review examines the rationale for anaesthesia and sedation during PFA, the mechanisms underlying pain, involuntary movement, and neuromuscular stimulation, and the implications of catheter design, waveform characteristics, and patient-related factors for peri-procedural management. Available evidence indicates that both deep sedation and general anaesthesia can provide safe and effective procedural conditions when supported by appropriate monitoring, airway rescue capability, and experienced multidisciplinary teams. Deep sedation may offer advantages in workflow, recovery, and patient-centred care, particularly for standard pulmonary vein isolation procedures using contemporary biphasic systems with reduced muscle activation, whereas general anaesthesia remains appropriate for complex procedures, patients with substantial comorbidity, or settings in which complete immobility and airway control are essential. Current real-world practice is highly heterogeneous across regions and institutions, reflecting differences in regulations, staffing models, procedural complexity, and local expertise rather than a universally accepted standard. Overall, anaesthetic strategy in PFA should be individualised according to patient risk profile, expected procedural demands, and device-specific stimulation burden. Further prospective comparative studies are needed to define optimal sedation depth, standardise monitoring and outcome measures, and clarify how emerging technologies may enable lighter yet still effective sedation pathways.
- Open Access
- 21 October 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (Supplement) , ii3-ii17
Biophysical principles of pulsed field ablation
Pulsed field ablation (PFA) is emerging as a major advance in cardiac ablation because it induces irreversible electroporation rather than relying primarily on thermal injury. This article provides an overview of the core biophysical principles underlying PFA, focusing on concepts broadly relevant across systems and clinical applications. Externally applied pulsed electric fields interact with biological tissues and affect their transmembrane potential. When a critical threshold is exceeded, nanoscale aqueous pores form in the lipid bilayer, initiating electroporation. Depending on pulse amplitude, duration, number, repetition frequency, waveform, and tissue characteristics, membrane permeabilization may remain reversible or progress to irreversible injury and cell death. This article focuses on the fundamental biophysical principles of electroporation that underpin PFA. The article outlines how membrane charging, cell geometry, and tissue heterogeneity influence electric field distribution and biological response and explains why lesion formation depends on both field intensity and exposure conditions. It also summarizes the molecular basis of pore formation, the potential contribution of lipid peroxidation and membrane proteins, and the downstream processes linking sustained permeability to loss of homeostasis and delayed cell death. Finally, it places cardiac PFA in the broader context of electroporation-based therapies developed in oncology, drug delivery, and gene transfer, while highlighting the remaining need for cardiomyocyte-specific mechanistic evidence to further optimize safety, precision, and durability.
- 21 October 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (Supplement) , ii3-ii17
Open AccessBiophysical principles of pulsed field ablation
Pulsed field ablation (PFA) is emerging as a major advance in cardiac ablation because it induces irreversible electroporation rather than relying primarily on thermal injury. This article provides an overview of the core biophysical principles underlying PFA, focusing on concepts broadly relevant across systems and clinical applications. Externally applied pulsed electric fields interact with biological tissues and affect their transmembrane potential. When a critical threshold is exceeded, nanoscale aqueous pores form in the lipid bilayer, initiating electroporation. Depending on pulse amplitude, duration, number, repetition frequency, waveform, and tissue characteristics, membrane permeabilization may remain reversible or progress to irreversible injury and cell death. This article focuses on the fundamental biophysical principles of electroporation that underpin PFA. The article outlines how membrane charging, cell geometry, and tissue heterogeneity influence electric field distribution and biological response and explains why lesion formation depends on both field intensity and exposure conditions. It also summarizes the molecular basis of pore formation, the potential contribution of lipid peroxidation and membrane proteins, and the downstream processes linking sustained permeability to loss of homeostasis and delayed cell death. Finally, it places cardiac PFA in the broader context of electroporation-based therapies developed in oncology, drug delivery, and gene transfer, while highlighting the remaining need for cardiomyocyte-specific mechanistic evidence to further optimize safety, precision, and durability.
- Open Access
- 3 March 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (5) , 895-905
Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues
Introduction: Cardiac contractility modulation (CCM) is a medical device‐based therapy delivering non‐excitatory electrical stimulations to the heart to enhance cardiac function in heart failure (HF) patients. The lack of human in vitro tools to assess CCM hinders our understanding of CCM mechanisms of action. Here, we introduce a novel chronic (i.e., 2‐day) in vitro CCM assay to evaluate the effects of CCM in a human 3D microphysiological system consisting of engineered cardiac tissues (ECTs).Methods: Cryopreserved human induced pluripotent stem cell‐derived cardiomyocytes were used to generate 3D ECTs. The ECTs were cultured, incorporating human primary ventricular cardiac fibroblasts and a fibrin‐based gel. Electrical stimulation was applied using two separate pulse generators for the CCM group and control group. Contractile properties and intracellular calcium were measured, and a cardiac gene quantitative PCR screen was conducted.Results: Chronic CCM increased contraction amplitude and duration, enhanced intracellular calcium transient amplitude, and altered gene expression related to HF (i.e., natriuretic peptide B, NPPB) and excitation‐contraction coupling (i.e., sodium‐calcium exchanger, SLC8).Conclusion: These data represent the first study of chronic CCM in a 3D ECT model, providing a nonclinical tool to assess the effects of cardiac electrophysiology medical device signals complementing in vivo animal studies. The methodology established a standardized 3D ECT‐based in vitro testbed for chronic CCM, allowing evaluation of physiological and molecular effects on human cardiac tissues.
- 3 March 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (5) , 895-905
Open AccessNonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues
Introduction: Cardiac contractility modulation (CCM) is a medical device‐based therapy delivering non‐excitatory electrical stimulations to the heart to enhance cardiac function in heart failure (HF) patients. The lack of human in vitro tools to assess CCM hinders our understanding of CCM mechanisms of action. Here, we introduce a novel chronic (i.e., 2‐day) in vitro CCM assay to evaluate the effects of CCM in a human 3D microphysiological system consisting of engineered cardiac tissues (ECTs).Methods: Cryopreserved human induced pluripotent stem cell‐derived cardiomyocytes were used to generate 3D ECTs. The ECTs were cultured, incorporating human primary ventricular cardiac fibroblasts and a fibrin‐based gel. Electrical stimulation was applied using two separate pulse generators for the CCM group and control group. Contractile properties and intracellular calcium were measured, and a cardiac gene quantitative PCR screen was conducted.Results: Chronic CCM increased contraction amplitude and duration, enhanced intracellular calcium transient amplitude, and altered gene expression related to HF (i.e., natriuretic peptide B, NPPB) and excitation‐contraction coupling (i.e., sodium‐calcium exchanger, SLC8).Conclusion: These data represent the first study of chronic CCM in a 3D ECT model, providing a nonclinical tool to assess the effects of cardiac electrophysiology medical device signals complementing in vivo animal studies. The methodology established a standardized 3D ECT‐based in vitro testbed for chronic CCM, allowing evaluation of physiological and molecular effects on human cardiac tissues.
- Open Access
- 2 November 2022
- Published by Wiley in Physiological Reports
- Vol. 10 (21) , e15498
Human in vitro neurocardiac coculture ( iv NCC ) assay development for evaluating cardiac contractility modulation
Two of the most prominent organ systems, the nervous and the cardiovascular systems, are intricately connected to maintain homeostasis in mammals. Recent years have shown tremendous efforts toward therapeutic modulation of cardiac contractility and electrophysiology by electrical stimulation. Neuronal innervation and cardiac ganglia regulation are often overlooked when developing in vitro models for cardiac devices, but it is likely that peripheral nervous system plays a role in the clinical effects. We developed an in vitro neurocardiac coculture (ivNCC) model system to study cardiac and neuronal interplay using human induced pluripotent stem cell (hiPSC) technology. We demonstrated significant expression and colocalization of cardiac markers including troponin, α‐actinin, and neuronal marker peripherin in neurocardiac coculture. To assess functional coupling between the cardiomyocytes and neurons, we evaluated nicotine‐induced β‐adrenergic norepinephrine effect and found beat rate was significantly increased in ivNCC as compared to monoculture alone. The developed platform was used as a nonclinical model for the assessment of cardiac medical devices that deliver nonexcitatory electrical pulses to the heart during the absolute refractory period of the cardiac cycle, that is, cardiac contractility modulation (CCM) therapy. Robust coculture response was observed at 14 V/cm (5 V, 64 mA), monophasic, 2 ms pulse duration for pacing and 20 V/cm (7 V, 90 mA) phase amplitude, biphasic, 5.14 ms pulse duration for CCM. We observed that the CCM effect and kinetics were more pronounced in coculture as compared to cardiac monoculture, supporting a hypothesis that some part of CCM mechanism of action can be attributed to peripheral nervous system stimulation. This study provides novel characterization of CCM effects on hiPSC‐derived neurocardiac cocultures. This innervated human heart model can be further extended to investigate arrhythmic mechanisms, neurocardiac safety, and toxicity post‐chronic exposure to materials, drugs, and medical devices. We present data on acute CCM electrical stimulation effects on a functional and optimized coculture using commercially available hiPSC‐derived cardiomyocytes and neurons. Moreover, this study provides an in vitro human heart model to evaluate neuronal innervation and cardiac ganglia regulation of contractility by applying CCM pulse parameters that closely resemble clinical setting. This ivNCC platform provides a potential tool for investigating aspects of cardiac and neurological device safety and performance.
- 2 November 2022
- Published by Wiley in Physiological Reports
- Vol. 10 (21) , e15498
Open AccessHuman in vitro neurocardiac coculture ( iv NCC ) assay development for evaluating cardiac contractility modulation
Two of the most prominent organ systems, the nervous and the cardiovascular systems, are intricately connected to maintain homeostasis in mammals. Recent years have shown tremendous efforts toward therapeutic modulation of cardiac contractility and electrophysiology by electrical stimulation. Neuronal innervation and cardiac ganglia regulation are often overlooked when developing in vitro models for cardiac devices, but it is likely that peripheral nervous system plays a role in the clinical effects. We developed an in vitro neurocardiac coculture (ivNCC) model system to study cardiac and neuronal interplay using human induced pluripotent stem cell (hiPSC) technology. We demonstrated significant expression and colocalization of cardiac markers including troponin, α‐actinin, and neuronal marker peripherin in neurocardiac coculture. To assess functional coupling between the cardiomyocytes and neurons, we evaluated nicotine‐induced β‐adrenergic norepinephrine effect and found beat rate was significantly increased in ivNCC as compared to monoculture alone. The developed platform was used as a nonclinical model for the assessment of cardiac medical devices that deliver nonexcitatory electrical pulses to the heart during the absolute refractory period of the cardiac cycle, that is, cardiac contractility modulation (CCM) therapy. Robust coculture response was observed at 14 V/cm (5 V, 64 mA), monophasic, 2 ms pulse duration for pacing and 20 V/cm (7 V, 90 mA) phase amplitude, biphasic, 5.14 ms pulse duration for CCM. We observed that the CCM effect and kinetics were more pronounced in coculture as compared to cardiac monoculture, supporting a hypothesis that some part of CCM mechanism of action can be attributed to peripheral nervous system stimulation. This study provides novel characterization of CCM effects on hiPSC‐derived neurocardiac cocultures. This innervated human heart model can be further extended to investigate arrhythmic mechanisms, neurocardiac safety, and toxicity post‐chronic exposure to materials, drugs, and medical devices. We present data on acute CCM electrical stimulation effects on a functional and optimized coculture using commercially available hiPSC‐derived cardiomyocytes and neurons. Moreover, this study provides an in vitro human heart model to evaluate neuronal innervation and cardiac ganglia regulation of contractility by applying CCM pulse parameters that closely resemble clinical setting. This ivNCC platform provides a potential tool for investigating aspects of cardiac and neurological device safety and performance.
- Open Access
- 27 October 2022
- Published by Wiley in Physiological Reports
- Vol. 10 (20) , e15493
Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
Pulse electric field‐based (PEF) ablation is a technique whereby short high‐intensity electric fields inducing irreversible electroporation (IRE) are applied to various tissues. Here, we implemented a standardized in vitro model to compare the effects of biphasic symmetrical pulses (100 pulses, 1–10 μs phase duration (d), 10–1000 Hz pulse repetition rate (f)) using two different human cellular models: human‐induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) and human esophageal smooth muscle cells (hESMCs) cultured in monolayer format. We report the PEF‐induced irreversibly electroporated cell monolayer areas and the corresponding electric field thresholds (EFTs) for both cardiac and esophageal cultures. Our results suggest marked cell type specificity with EFT estimated to be 2–2.5 times lower in hiPSC‐CMs than in hESMCs when subjected to identical PEF treatments (e.g., 0.90 vs 1.85 kV/cm for the treatment of 100 pulses with d = 5 μs, f = 10 Hz, and 0.65 vs 1.67 kV/cm for the treatment of 100 pulses with d = 10 μs, f = 10 Hz). PEF treatment can result in increased temperature around the stimulating electrodes and lead to unanticipated thermal tissue damage that is proportional to the peak temperature rise and to the duration of the PEF‐induced elevated temperatures. In our study, temperature increases ranged from less than 1°C to as high as 30°C, however, all temperature changes were transient and quickly returned to baseline and the highest observed ∆T returned to 50% of its maximum recorded temperature in tens of seconds.
- 27 October 2022
- Published by Wiley in Physiological Reports
- Vol. 10 (20) , e15493
Open AccessHuman cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
Pulse electric field‐based (PEF) ablation is a technique whereby short high‐intensity electric fields inducing irreversible electroporation (IRE) are applied to various tissues. Here, we implemented a standardized in vitro model to compare the effects of biphasic symmetrical pulses (100 pulses, 1–10 μs phase duration (d), 10–1000 Hz pulse repetition rate (f)) using two different human cellular models: human‐induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) and human esophageal smooth muscle cells (hESMCs) cultured in monolayer format. We report the PEF‐induced irreversibly electroporated cell monolayer areas and the corresponding electric field thresholds (EFTs) for both cardiac and esophageal cultures. Our results suggest marked cell type specificity with EFT estimated to be 2–2.5 times lower in hiPSC‐CMs than in hESMCs when subjected to identical PEF treatments (e.g., 0.90 vs 1.85 kV/cm for the treatment of 100 pulses with d = 5 μs, f = 10 Hz, and 0.65 vs 1.67 kV/cm for the treatment of 100 pulses with d = 10 μs, f = 10 Hz). PEF treatment can result in increased temperature around the stimulating electrodes and lead to unanticipated thermal tissue damage that is proportional to the peak temperature rise and to the duration of the PEF‐induced elevated temperatures. In our study, temperature increases ranged from less than 1°C to as high as 30°C, however, all temperature changes were transient and quickly returned to baseline and the highest observed ∆T returned to 50% of its maximum recorded temperature in tens of seconds.
- Open Access
- 3 November 2021
- Published by Wiley in Physiological Reports
- Vol. 9 (21) , e15085
Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
HiPSC-CMs’ contractility increases in response to biphasic nonexcitatory electrical pulses delivered during refractory period mimicking clinical CCM device therapy. CCM-induced inotropic effects to b...
- 3 November 2021
- Published by Wiley in Physiological Reports
- Vol. 9 (21) , e15085
Open AccessAcute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
HiPSC-CMs’ contractility increases in response to biphasic nonexcitatory electrical pulses delivered during refractory period mimicking clinical CCM device therapy. CCM-induced inotropic effects to b...
- 1 August 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Annual International Conference of the IEEE Engineering in Medicine and Biology Society
- Vol. 2016 (1557170X) , 4232-4235
Microchambers for cell exposure: From the design to applications
In the last decades, the advances in the micro and nano fabrication techniques have led to the development of microdevices that improved the possibility of analysis at cell level. These devices can be used in different applications (e.g., cell detection and identification, manipulation, cell treatments). The requisites, that are necessary to achieve, are different for various applications and represent the starting point of the project. The numerical multiphysics models can be very advantageous to analyze the performances of such devices and to predict their operation. Aim of this work is to give a look of the design rules of microchamber devices in particular for their application in electric field exposure. Two different applications for cell discrimination and characterization are reported considering time and frequency domain measurements.
- 1 August 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Annual International Conference of the IEEE Engineering in Medicine and Biology Society
- Vol. 2016 (1557170X) , 4232-4235
Microchambers for cell exposure: From the design to applications
In the last decades, the advances in the micro and nano fabrication techniques have led to the development of microdevices that improved the possibility of analysis at cell level. These devices can be used in different applications (e.g., cell detection and identification, manipulation, cell treatments). The requisites, that are necessary to achieve, are different for various applications and represent the starting point of the project. The numerical multiphysics models can be very advantageous to analyze the performances of such devices and to predict their operation. Aim of this work is to give a look of the design rules of microchamber devices in particular for their application in electric field exposure. Two different applications for cell discrimination and characterization are reported considering time and frequency domain measurements.
- 1 June 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
A numerical design of versatile microchambers for nsPEFs experiments
The emergence of nanosecond pulsed electric fields (nsPEFs) for intracellular electro-manipulation experiments implies the application of extremely short (ns) high intensity (MV/m) electric field pulses. Specific pulse generators and miniaturized applicators are necessary to properly deliver this category of voltage signals to biological loads. In this context, we propose the design of a versatile nsPEFs applicator, developed following the guidelines typical of microwave propagating systems. The designed microchamber is suitable for in vitro exposure to undistorted pulses with duration down to 1-3 ns during single and multi cell experiments. Further features are: high efficiency (above 0.95), high cell viability by the integration of microfluidic components, real time monitoring of the biological sample and of the pulse propagation. These features can be considered as designing rules for new nanosecond and sub-nanosecond applicators, to ensure experimental repeatability and reproducibility when the impact of propagation on pulse signals is no more negligible.
- 1 June 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
A numerical design of versatile microchambers for nsPEFs experiments
The emergence of nanosecond pulsed electric fields (nsPEFs) for intracellular electro-manipulation experiments implies the application of extremely short (ns) high intensity (MV/m) electric field pulses. Specific pulse generators and miniaturized applicators are necessary to properly deliver this category of voltage signals to biological loads. In this context, we propose the design of a versatile nsPEFs applicator, developed following the guidelines typical of microwave propagating systems. The designed microchamber is suitable for in vitro exposure to undistorted pulses with duration down to 1-3 ns during single and multi cell experiments. Further features are: high efficiency (above 0.95), high cell viability by the integration of microfluidic components, real time monitoring of the biological sample and of the pulse propagation. These features can be considered as designing rules for new nanosecond and sub-nanosecond applicators, to ensure experimental repeatability and reproducibility when the impact of propagation on pulse signals is no more negligible.